PrintFriendly

Print Friendly, PDF & Email

uniQure Announces Initial Data Showing Positive Early Results from Hemophilia B Gene Therapy

Jonathan Angarola's picture
Submitted by Jonathan Angarola on November 19, 2018 - 10:38
uniQure Announces Initial Data Showing Positive Early Results from Hemophilia B Gene Therapy

UniQure recently announced initial clinical data from patients treated in an open-label phase IIb dose-confirmation study of AMT-061, the company’s investigational gene therapy treatment for patients with severe and moderately severe hemophilia B.

Pages